Matthew J Peerce

Array ( [id] => 8760151 [patent_doc_number] => 08420672 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Solid forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindo1-2-yl)-piperidine-2,6-dione and methods of making the same' [patent_app_type] => utility [patent_app_number] => 12/885065 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 609 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12885065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371385 [patent_doc_number] => 20120220777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'PROCESS FOR THE PREPARATION OF A CRYSTALLINE FORM OF LENALIDOMIDE' [patent_app_type] => utility [patent_app_number] => 13/395922 [patent_app_country] => US [patent_app_date] => 2010-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 1487 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10182482 [patent_doc_number] => 09212155 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-15 [patent_title] => 'Compounds advantageous in the treatment of central nervous system diseases and disorders' [patent_app_type] => utility [patent_app_number] => 12/881068 [patent_app_country] => US [patent_app_date] => 2010-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 35 [patent_no_of_words] => 19390 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12881068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144838 [patent_doc_number] => 20110130429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE' [patent_app_type] => utility [patent_app_number] => 12/878495 [patent_app_country] => US [patent_app_date] => 2010-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15908 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130429.pdf [firstpage_image] =>[orig_patent_app_number] => 12878495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228724 [patent_doc_number] => 20120142932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'METHOD FOR MANUFACTURING 4-(5-METHYLPYRIDIN-2-YLAMINO)PIPERIDINE-1-CARBOXYLIC ACID DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/386698 [patent_app_country] => US [patent_app_date] => 2010-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4504 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8302188 [patent_doc_number] => 20120184746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'PROCESS FOR THE PREPARATION OF LENALIDOMIDE' [patent_app_type] => utility [patent_app_number] => 13/393699 [patent_app_country] => US [patent_app_date] => 2010-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3519 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9496771 [patent_doc_number] => 08735589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-27 [patent_title] => 'Process for the synthesis of naratriptan' [patent_app_type] => utility [patent_app_number] => 13/390455 [patent_app_country] => US [patent_app_date] => 2010-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8895 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228732 [patent_doc_number] => 20120142928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'PROCESS FOR THE PREPARATION OF CATHEPSIN S INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/389790 [patent_app_country] => US [patent_app_date] => 2010-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 45519 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211942 [patent_doc_number] => 20120130077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'BENZYL PIPERIDINE COMPOUND' [patent_app_type] => utility [patent_app_number] => 13/388623 [patent_app_country] => US [patent_app_date] => 2010-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27761 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20120130077.pdf [firstpage_image] =>[orig_patent_app_number] => 13388623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9662404 [patent_doc_number] => 08809380 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Picolinamide derivatives as TTX-S blockers' [patent_app_type] => utility [patent_app_number] => 13/388740 [patent_app_country] => US [patent_app_date] => 2010-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36329 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6403982 [patent_doc_number] => 20100305328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'PROCESS FOR PREPARATION OF PIPERIDINE CARBOXYLIC ACID' [patent_app_type] => utility [patent_app_number] => 12/846479 [patent_app_country] => US [patent_app_date] => 2010-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3163 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305328.pdf [firstpage_image] =>[orig_patent_app_number] => 12846479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8382233 [patent_doc_number] => 20120225862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'HETEROARYL BENZAMIDES, COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/384978 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 75893 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6448364 [patent_doc_number] => 20100280072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => '2-\'4-(HYDROXYMETHYL-PHENYLAMINO) -PIPERIDINE-1-YL!-N- (9H-CARBAZOL-3YL) - ACETAMINE DERIVATIVES AND RELATED COMPOUNDS AS NEUROPEPTIDE Y5 (NPY5) LIGANDS FOR THE TREATMENT OF OBESITY' [patent_app_type] => utility [patent_app_number] => 12/834211 [patent_app_country] => US [patent_app_date] => 2010-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9131 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280072.pdf [firstpage_image] =>[orig_patent_app_number] => 12834211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6576488 [patent_doc_number] => 20100273794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Benzimidazolone Compounds Having 5-HT4 Receptor Agonistic Activity' [patent_app_type] => utility [patent_app_number] => 12/831713 [patent_app_country] => US [patent_app_date] => 2010-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25216 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273794.pdf [firstpage_image] =>[orig_patent_app_number] => 12831713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6098509 [patent_doc_number] => 20110003996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Crystal Forms of (3R)-1-(2-Methylalanyl-D-Tryptophyl)-3-(Phenylmethyl)-3-Piperidinecarboxylic Acid 1,2,2-Trimethylhydrazide' [patent_app_type] => utility [patent_app_number] => 12/831009 [patent_app_country] => US [patent_app_date] => 2010-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11511 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003996.pdf [firstpage_image] =>[orig_patent_app_number] => 12831009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929843 [patent_doc_number] => 20110039802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'NPY Y5 ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 12/830282 [patent_app_country] => US [patent_app_date] => 2010-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47415 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039802.pdf [firstpage_image] =>[orig_patent_app_number] => 12830282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7762953 [patent_doc_number] => 08115027 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-14 [patent_title] => 'NPY Y5 antagonist' [patent_app_type] => utility [patent_app_number] => 12/830272 [patent_app_country] => US [patent_app_date] => 2010-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47348 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/115/08115027.pdf [firstpage_image] =>[orig_patent_app_number] => 12830272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8921056 [patent_doc_number] => 08486992 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Carboxamide derivatives as muscarinic receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/828732 [patent_app_country] => US [patent_app_date] => 2010-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63083 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12828732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6630982 [patent_doc_number] => 20100311753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'C5aR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/823039 [patent_app_country] => US [patent_app_date] => 2010-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 23513 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311753.pdf [firstpage_image] =>[orig_patent_app_number] => 12823039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8265892 [patent_doc_number] => 20120165320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'NOVEL AZABICYCLOHEXANES' [patent_app_type] => utility [patent_app_number] => 13/380744 [patent_app_country] => US [patent_app_date] => 2010-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39043 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13380744 [rel_patent_id] =>[rel_patent_doc_number] =>)